ArticleCureus2025
Mandibular Follicular Lymphoma: A Rare Extranodal Presentation With Initial Facial Bone Involvement.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular lymphoma is a common subtype of B-cell non-Hodgkin lymphoma, typically presenting with nodal involvement and, less frequently, in extranodal locations. Primary involvement of the mandible is extremely rare and is often mistaken for odontogenic or inflammatory pathologies, leading to delayed diagnosis. We present the case of a 73-year-old female patient with progressive swelling of the left hemimandible, associated with hypoesthesia of the ipsilateral lower lip. Computed tomography revealed an infiltrative soft tissue lesion with cortical bone erosion and involvement of the inferior alveolar canal. Flow cytometry identified a clonal population of CD20+, CD10+, and BCL2+ B cells, consistent with a diagnosis of follicular lymphoma. Staging with positron emission tomography demonstrated additional extranodal involvement, establishing the disease as Ann Arbor stage IV. The patient was proposed for systemic chemotherapy with rituximab, cyclophosphamide, vincristine, and prednisone, followed by maintenance with rituximab, showing marked clinical and functional improvement after the second treatment cycle. This case highlights the importance of considering lymphoproliferative disorders in the differential diagnosis of persistent mandibular masses. It also underscores the value of flow cytometry in evaluating complex oral presentations and emphasizes the role of a multidisciplinary approach for early diagnosis and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.